Related Experiment Video
Updated: May 24, 2026

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
Published on: June 28, 2024
Meningioma as second malignant neoplasm after oncological treatment during childhood
H L Müller1, U Gebhardt, M Warmuth-Metz
1Department of Pediatric Hematology and Oncology, Zentrum für Kinder- und Jugendmedizin, Klinikum Oldenburg, Rahel-Straus-Str. 10, 26133, Oldenburg, Germany. mueller.hermann@klinikum-oldenburg.de
Abstract:
A total of 38 patients (18 female/20 male) with childhood meningioma were recruited from the German registry HIT-Endo (1989-2009). In 5 cases meningioma occurred as second malignant neoplasm (SMN). Histologies were confirmed by reference assessment in all cases (SMN: 2 WHO I, 1 WHO II, 2 WHO III). The SMNs were diagnosed at a median age of 12.4 years with a median latency of 10.2 years after primary malignancy (PMN; 4 brain tumors, 1 lymphoblastic leukemia; median age at diagnosis 2.7 years). Meningioma occurred as SMN in the irradiated field of PMN (range 12-54 Gy). The outcome after treatment of SMN meningioma (surgery/irradiation) was favorable in terms of psychosocial status and functional capacity in 4 of 5 patients (1 death). We conclude that survivors of childhood cancer who were exposed to radiation therapy at young age harbor the risk of developing meningioma as a SMN at a particularly short latency period in case of high dose exposure.
Insights
Childhood cancer survivors exposed to radiation therapy may develop meningioma as a second malignant neoplasm (SMN). High-dose radiation increases the risk of SMN meningioma with a short latency period.
Area of Science:
- Pediatric Oncology
- Neuro-oncology
- Radiation Oncology
Background:
- Childhood meningioma is a rare primary brain tumor.
- Understanding the risk of secondary meningioma in childhood cancer survivors is crucial.
Observation:
- A German registry identified 38 patients with childhood meningioma.
- Five cases (13%) were secondary malignant neoplasms (SMNs), diagnosed at a median age of 12.4 years.
- These SMNs occurred after primary malignancies (e.g., brain tumors, leukemia) treated with radiation (12-54 Gy).
Findings:
- Median latency for SMN meningioma was 10.2 years after primary malignancy.
- Histologies included WHO grades I, II, and III.
- Treatment outcomes for SMN meningioma were generally favorable (4/5 patients), with one death.
Implications:
- Childhood cancer survivors treated with radiation are at risk for developing meningioma as a SMN.
- High-dose radiation and young age at exposure are associated with a shorter latency period for SMN meningioma.
- Long-term surveillance for secondary neoplasms in pediatric cancer survivors is warranted.
More Related Videos
Related Concept Videos
Bacterial Meningitis I: Introduction
Bacterial Meningitis II: Pathophysiology
Viral Meningitis
Encephalitis l: Introduction
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...

